Puerperal streptococcal toxic shock syndrome treated with recombinant human activated protein C and intravenous immunoglobulin

被引：7
作者：
Al-Rawi, S. [1 ]
Woodward, L. J. [1 ]
Knight, J. [2 ]
机构：
[1] Southampton Univ Hosp NHS Trust, Shackleton Dept Anaesthesia, Southampton SO16 6YD, Hants, England
[2] N Hampshire Hosp NHS Fdn Trust, Basingstoke, Hants, England
来源：
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA | 2009年 / 18卷 / 02期
关键词：
Puerperal sepsis; Group A streptococcal infections; Recombinant human activated protein C; Intravenous immunoglobulin; Heparin-induced thrombocytopenia; SEVERE SEPSIS; EFFICACY; PATIENT; ADULT;
D O I：
10.1016/j.ijoa.2008.10.003
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Group A streptococcal sepsis is an uncommon management challenge and has a potentially fulminate course. We present the case of a 25-year-old woman who, within 24 It of spontaneous vaginal delivery at 32 weeks of gestation, developed signs of systemic infection and multi-organ failure requiring admission to the intensive care Unit. Recombinant human activated protein C and intravenous immunoglobulin were used subsequently heparin-induced thrombocytopenia and pulmonary embolus also required treatment. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：169 / 172
页数：4
相关论文
共 14 条
  • [1] [Anonymous], European public assessment report
  • [2] Severe group A streptococcal infection and streptococcal toxic shock syndrome
    Baxter, F
    McChesney, J
    [J]. CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2000, 47 (11): : 1129 - 1140
  • [3] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [4] DEFINING THE GROUP-A STREPTOCOCCAL TOXIC SHOCK SYNDROME - RATIONALE AND CONSENSUS DEFINITION
    BREIMAN, RF
    DAVIS, JP
    FACKLAM, RR
    GRAY, BM
    HOGE, CW
    KAPLAN, EL
    MORTIMER, EA
    SCHLIEVERT, PM
    SCHWARTZ, B
    STEVENS, DL
    TODD, JK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (03): : 390 - 391
  • [5] THE PROTEIN-C ANTICOAGULANT PATHWAY
    ESMON, CT
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (02): : 135 - 145
  • [6] Case mix, outcome and activity for obstetric admissions to adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database
    Harrison, David A.
    Penny, James A.
    Yentis, Steve M.
    Fayek, Samia
    Brady, Anthony R.
    [J]. CRITICAL CARE, 2005, 9 (Suppl 3): : S25 - S27
  • [7] Incidence, treatment and outcome of peripartum sepsis
    Kankuri, E
    Kurki, T
    Carlson, P
    Hiilesmaa, V
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (08) : 730 - 735
  • [8] Mahabeer N, 2005, HOSP MED, V66, P124
  • [9] Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation:: A case report
    Medve, L
    Csitári, IK
    Molnár, Z
    László, A
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (03) : 864 - 865
  • [10] Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: Implications for therapeutic efficacy
    Norrby-Teglund, A
    Basma, H
    Andersson, J
    McGeer, A
    Low, DE
    Koth, M
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (03) : 631 - 638
12